Abstract
A group of class I selective HDAC inhibitors were derived previously, with inhibitory preference of HDAC1 and HDAC3 over HDAC2. Molecular docking and molecular dynamic simulation approaches were performed to elucidate the structural basis of inhibitor’s selectivity between HDAC2 and HDAC3. Superimposition of the rigid docked structures showed that residues in the active sites of both receptors are identical, and the inhibitor (D18) has similar binding patterns in both sites. Results of the flexible docking suggested that strong hydrophobic interactions between molecule D18 and Phe199 play significant role in the selectivity. The interactions were verified to be stable by further molecular dynamic simulation processes.
Keywords: HDAC, inhibitor, selectivity, flexible docking, molecular dynamic simulation.
Letters in Drug Design & Discovery
Title:Molecular Simulation of HDAC1/3 Inhibitor: Insights into the Structural Basis of Selectivity
Volume: 13 Issue: 1
Author(s): Lei Zhang and Lihui Zhang
Affiliation:
Keywords: HDAC, inhibitor, selectivity, flexible docking, molecular dynamic simulation.
Abstract: A group of class I selective HDAC inhibitors were derived previously, with inhibitory preference of HDAC1 and HDAC3 over HDAC2. Molecular docking and molecular dynamic simulation approaches were performed to elucidate the structural basis of inhibitor’s selectivity between HDAC2 and HDAC3. Superimposition of the rigid docked structures showed that residues in the active sites of both receptors are identical, and the inhibitor (D18) has similar binding patterns in both sites. Results of the flexible docking suggested that strong hydrophobic interactions between molecule D18 and Phe199 play significant role in the selectivity. The interactions were verified to be stable by further molecular dynamic simulation processes.
Export Options
About this article
Cite this article as:
Zhang Lei and Zhang Lihui, Molecular Simulation of HDAC1/3 Inhibitor: Insights into the Structural Basis of Selectivity, Letters in Drug Design & Discovery 2016; 13 (1) . https://dx.doi.org/10.2174/1570180812666150630183816
DOI https://dx.doi.org/10.2174/1570180812666150630183816 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Circulating MicroRNAs as Biomarkers for Inflammatory Diseases
MicroRNA Rhinocerebral Mucormycosis with Orosinusal Involvement: Diagnostic and Surgical Treatment Guidelines
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacogenomics of Methotrexate: Current Status and Future Outlook
Current Drug Metabolism Tip60: Main Functions and Its Inhibitors
Mini-Reviews in Medicinal Chemistry One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology Caspases: Structure-Guided Design of Drugs to Control Cell Death
Mini-Reviews in Medicinal Chemistry Targeting Trail Towards the Clinic
Current Drug Targets Lipid-Based Drug Delivery Systems for Cancer Treatment
Current Drug Targets RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery
Mini-Reviews in Medicinal Chemistry Novel Drugs Targeting Microtubules: the Role of Epothilones
Current Pharmaceutical Design Cancer Therapeutics: Emerging Targets and Trends
Current Cancer Therapy Reviews Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Current Pharmaceutical Design Antioxidant Properties of Crocus Sativus L. and Its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and Parkinson’s Disease
Current Neuropharmacology Immunological Aspects of Adult T-Cell Leukemia/Lymphoma (ATLL), a Possible Neoplasm of Regulatory T-Cells
Current Immunology Reviews (Discontinued) The Impacts of Non-coding RNAs and N<sup>6</sup>-Methyladenosine on Cancer: Past, Present and Future
Current Cancer Drug Targets Bladder Cancer: Molecular Determinants of Personalized Therapy
Current Drug Targets Novel Marine-Derived Anti-Cancer Agents
Current Pharmaceutical Design The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Subject Index to Volume 7
Combinatorial Chemistry & High Throughput Screening Cruciferous Plants: Phytochemical Toxicity Versus Cancer Chemoprotection
Mini-Reviews in Medicinal Chemistry